{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:05:44Z","timestamp":1792789544886,"version":"4.5.0"},"reference-count":80,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education of the Russian Federation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Genome editing is currently widely used in biomedical research; however, the use of this method in the clinic is still limited because of its low efficiency and possible side effects. Moreover, the correction of mutations that cause diseases in humans seems to be extremely important and promising. Numerous attempts to improve the efficiency of homology-directed repair-mediated correction of mutations in mammalian cells have focused on influencing the cell cycle. Homology-directed repair is known to occur only in the late S and G2 phases of the cell cycle, so researchers are looking for safe ways to enrich the cell culture with cells in these phases of the cell cycle. This review surveys the main approaches to influencing the cell cycle in genome editing experiments (predominantly using Cas9), for example, the use of cell cycle synchronizers, mitogens, substances that affect cyclin-dependent kinases, hypothermia, inhibition of p53, etc. Despite the fact that all these approaches have a reversible effect on the cell cycle, it is necessary to use them with caution, since cells during the arrest of the cell cycle can accumulate mutations, which can potentially lead to their malignant transformation.<\/jats:p>","DOI":"10.3390\/ijms23115992","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T08:50:22Z","timestamp":1653555022000},"page":"5992","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Improving Homology-Directed Repair in Genome Editing Experiments by Influencing the Cell Cycle"],"prefix":"10.3390","volume":"23","author":[{"given":"Svetlana A.","family":"Smirnikhina","sequence":"first","affiliation":[{"name":"Research Centre for Medical Genetics, Laboratory of Genome Editing, 115478 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milyausha I.","family":"Zaynitdinova","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, Laboratory of Genome Editing, 115478 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilina A.","family":"Sergeeva","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, Laboratory of Genome Editing, 115478 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Lavrov","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, Laboratory of Genome Editing, 115478 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nbt1353","article-title":"Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery","volume":"25","author":"Lombardo","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.stem.2009.05.023","article-title":"Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells","volume":"5","author":"Zou","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nbt.1927","article-title":"Genetic engineering of human pluripotent cells using TALE nucleases","volume":"29","author":"Hockemeyer","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","article-title":"CRISPR\/Cas9 for genome editing: Progress, implications and challenges","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-9525(00)02022-9","article-title":"Partners and pathways repairing a double-strand break","volume":"16","author":"Haber","year":"2000","journal-title":"Trends Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.R700039200","article-title":"The mechanism of human nonhomologous DNA end joining","volume":"283","author":"Lieber","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0027-5107(01)00115-4","article-title":"Homologous recombinational repair of DNA ensures mammalian chromosome stability","volume":"477","author":"Thompson","year":"2001","journal-title":"Mutat. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4939-0888-2_2","article-title":"Cell cycle regulation by checkpoints","volume":"1170","author":"Barnum","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","article-title":"The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway","volume":"79","author":"Lieber","year":"2010","journal-title":"Annu. Rev. BioChem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1093\/emboj\/17.18.5497","article-title":"Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells","volume":"17","author":"Takata","year":"1998","journal-title":"EMBO J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature24023","article-title":"Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN","volume":"549","author":"Arnoult","year":"2017","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-018-1953-5","article-title":"Ways of improving precise knock-in by genome-editing technologies","volume":"138","author":"Smirnikhina","year":"2019","journal-title":"Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568011023354290","article-title":"Mechanism of action of antitumor drugs that interact with microtubules and tubulin","volume":"2","author":"Jordan","year":"2002","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0955-0674(98)80082-3","article-title":"Tubulin and microtubule structure","volume":"10","author":"Downing","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.biochem.69.1.277","article-title":"Structural insights into microtubule function","volume":"69","author":"Nogales","year":"2000","journal-title":"Annu. Rev. BioChem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2184.2011.00767.x","article-title":"Monitoring the fidelity of mitotic chromosome segregation by the spindle assembly checkpoint","volume":"44","author":"Silva","year":"2011","journal-title":"Cell Prolif."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Carlomagno, T. (2009). Tubulin-binding Agents: Synthetic, Structural and Mechanistic Insights, Springer.","DOI":"10.1007\/978-3-540-69039-9"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Fojo, T. (2008). An Overview of Compounds That Interact with Tubulin and Their Effects on Microtubule Assembly. The Role of Microtubules in Cell Biology, Neurobiology, and Oncology, Humana Press. Cancer Drug Discovery and, Development.","DOI":"10.1007\/978-1-59745-336-3"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e04766","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin","year":"2014","journal-title":"Elife"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.omtn.2019.12.021","article-title":"A Universal Surrogate Reporter for Efficient Enrichment of CRISPR\/Cas9-Mediated Homology-Directed Repair in Mammalian Cells","volume":"19","author":"Yan","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/hum.2012.168","article-title":"The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting","volume":"24","author":"Rahman","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13059-017-1164-8","article-title":"Efficient precise knockin with a double cut HDR donor after CRISPR\/Cas9-mediated double-stranded DNA cleavage","volume":"18","author":"Zhang","year":"2017","journal-title":"Genome Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"21264","DOI":"10.1038\/srep21264","article-title":"Enrichment of G2\/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1038\/s41598-017-02785-y","article-title":"Optimization of a CRISPR\/Cas9-mediated Knock-in Strategy at the Porcine Rosa26 Locus in Porcine Foetal Fibroblasts","volume":"7","author":"Xie","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/febs.13555","article-title":"Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery","volume":"283","author":"Wang","year":"2016","journal-title":"FEBS J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejps.2019.01.028","article-title":"Towards modern anticancer agents that interact with tubulin","volume":"131","author":"Coluccia","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1101\/gad.7.5.812","article-title":"Cyclin D1 is a nuclear protein required for cell cycle progression in G1","volume":"7","author":"Baldin","year":"1993","journal-title":"Genes Dev."},{"key":"ref_28","first-page":"3208","article-title":"Mechanism of action of E7010, an orally active sulfonamide antitumor agent: Inhibition of mitosis by binding to the colchicine site of tubulin","volume":"57","author":"Yoshimatsu","year":"1997","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1158\/1078-0432.CCR-05-2159","article-title":"The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: Results of a phase 1 study","volume":"12","author":"Hande","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_30","first-page":"1231","article-title":"Vinca alkaloids","volume":"4","author":"Moudi","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/bse0480107","article-title":"Epigenetic dynamics across the cell cycle","volume":"48","author":"Lund","year":"2010","journal-title":"Essays BioChem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1073\/pnas.0913668107","article-title":"E3 ubiquitin ligase APC\/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation","volume":"107","author":"Almeida","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/1947601912473307","article-title":"Flipping the switch from g1 to s phase with e3 ubiquitin ligases","volume":"3","author":"Rizzardi","year":"2012","journal-title":"Genes Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.celrep.2016.01.019","article-title":"Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair","volume":"14","author":"Gutschner","year":"2016","journal-title":"Cell Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.stemcr.2016.07.001","article-title":"A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells","volume":"7","author":"Howden","year":"2016","journal-title":"Stem Cell Reports"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gerlach, M., Kraft, T., Brenner, B., Petersen, B., Niemann, H., and Montag, J. (2018). Efficient Knock-in of a Point Mutation in Porcine Fibroblasts Using the CRISPR\/Cas9-GMNN Fusion Gene. Genes, 9.","DOI":"10.3390\/genes9060296"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.omtn.2019.02.009","article-title":"The Chromatin Structure of CRISPR-Cas9 Target DNA Controls the Balance between Mutagenic and Homology-Directed Gene-Editing Events","volume":"16","author":"Janssen","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.celrep.2018.11.019","article-title":"Shortening the Half-Life of Cas9 Maintains Its Gene Editing Ability and Reduces Neuronal Toxicity","volume":"25","author":"Yang","year":"2018","journal-title":"Cell Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s42003-020-01340-2","article-title":"A cell cycle-dependent CRISPR-Cas9 activation system based on an anti-CRISPR protein shows improved genome editing accuracy","volume":"3","author":"Matsumoto","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcp.2019.05.008","article-title":"Aflatoxin B1 induces S phase arrest by upregulating the expression of p21 via MYC, PLK1 and PLD1","volume":"166","author":"Huang","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00432-004-0579-2","article-title":"Molecular mechanisms of indirubin and its derivatives: Novel anticancer molecules with their origin in traditional Chinese phytomedicine","volume":"130","author":"Eisenbrand","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bcp.2008.01.021","article-title":"Critical role of Bid and Bax in indirubin-3\u2032-monoxime-induced apoptosis in human cancer cells","volume":"75","author":"Shi","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.dnarep.2018.09.003","article-title":"Regulation of the initiation of DNA replication in human cells","volume":"72","author":"Moiseeva","year":"2018","journal-title":"DNA Repair"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/s41467-020-16643-5","article-title":"Synergistic gene editing in human iPS cells via cell cycle and DNA repair modulation","volume":"11","author":"Maurissen","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/s41467-020-15845-1","article-title":"Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair","volume":"11","author":"Wienert","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41421-018-0049-7","article-title":"Programmable DNA repair with CRISPRa\/i enhanced homology-directed repair efficiency with a single Cas9","volume":"4","author":"Ye","year":"2018","journal-title":"Cell Discov."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/mol.115.099325","article-title":"Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics","volume":"88","author":"Law","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Gomez, V., and Hergovich, A. (2016). Cell-Cycle Control and DNA-Damage Signaling in Mammals. Genome Stability, Academic Press. From Virus to Human Application.","DOI":"10.1016\/B978-0-12-803309-8.00014-8"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/hum.2011.140","article-title":"Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors","volume":"23","author":"Gellhaus","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","article-title":"Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response","volume":"24","author":"Schiroli","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1093\/nar\/gkaa603","article-title":"CRISPR\/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells","volume":"48","author":"Geisinger","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41556-020-0472-5","article-title":"Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing","volume":"22","author":"Artegiani","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e8679","DOI":"10.15252\/msb.20188679","article-title":"CRISPR screens are feasible in TP53 wild-type cells","volume":"15","author":"Brown","year":"2019","journal-title":"Mol. Syst. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/scbi.1998.0098","article-title":"p53 and apoptosis","volume":"8","author":"Gottlieb","year":"1998","journal-title":"Semin. Cancer Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molmed.2018.06.010","article-title":"CRISPR: Stressed about p53?","volume":"24","author":"Foronda","year":"2018","journal-title":"Trends Mol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41588-020-0623-4","article-title":"Cas9 activates the p53 pathway and selects for p53-inactivating mutations","volume":"52","author":"Enache","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1093\/nar\/gkaa1002","article-title":"A unified model for the G1\/S cell cycle transition","volume":"48","author":"Hume","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2014.01.011","article-title":"Epidermal growth factor, from gene organization to bedside","volume":"28","author":"Zeng","year":"2014","journal-title":"Semin Cell Dev. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4065\/81.9.1241","article-title":"Biology of platelet-derived growth factor and its involvement in disease","volume":"81","author":"Alvarez","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"ref_62","first-page":"444","article-title":"Vascular endothelial growth factor (VEGF)\u2014Part 1: In physiology and pathophysiology","volume":"62","author":"Kajdaniuk","year":"2011","journal-title":"Endokrynol. Pol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/CCO.0b013e3282f5271c","article-title":"The MAPK pathway in melanoma","volume":"20","author":"Fecher","year":"2008","journal-title":"Curr. Opin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","article-title":"The MAPK signalling pathways and colorectal cancer","volume":"6","author":"Fang","year":"2005","journal-title":"Lancet Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2016.12.001","article-title":"Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK","volume":"53","author":"Martinelli","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"d447","DOI":"10.2741\/A291","article-title":"Role of E2F in cell cycle control and cancer","volume":"3","author":"Johnson","year":"1998","journal-title":"Front. Biosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","article-title":"Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization","volume":"12","author":"Diehl","year":"1998","journal-title":"Genes Dev."},{"key":"ref_69","first-page":"462","article-title":"Phytohemagglutinin: An initiator of mitosis in cultures of normal human leukocytes","volume":"20","author":"Nowell","year":"1960","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.celrep.2018.04.103","article-title":"Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome","volume":"23","author":"Kuo","year":"2018","journal-title":"Cell Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-2926-9_8","article-title":"Cell Synchronization Techniques to Study the Action of CDK Inhibitors","volume":"1336","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"32681","DOI":"10.1038\/srep32681","article-title":"Analyses of point mutation repair and allelic heterogeneity generated by CRISPR\/Cas9 and single-stranded DNA oligonucleotides","volume":"6","author":"Bialk","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Tsakraklides, V., Brevnova, E., Stephanopoulos, G., and Shaw, A.J. (2015). Improved Gene Targeting through Cell Cycle Synchronization. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133434"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nbt.2021.01.007","article-title":"Hydroxyurea selection for enhancement of homology-directed targeted integration of transgenes in CHO cells","volume":"62","author":"Kwak","year":"2021","journal-title":"N Biotechnol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10529-019-02671-9","article-title":"Expression and hydroxyurea-triggered induction of EGFP upon CRISPR\/Cas9-mediated integration into the \u03b3-globin gene of K562 cells","volume":"41","author":"Jafari","year":"2019","journal-title":"Biotechnol. Lett."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1742-4658.2008.06781.x","article-title":"Biochemical insights into the mechanisms central to the response of mammalian cells to cold stress and subsequent rewarming","volume":"276","author":"Roobol","year":"2009","journal-title":"FEBS J."},{"key":"ref_77","first-page":"605","article-title":"Hypothermia causes a reversible, p53-mediated cell cycle arrest in cultured fibroblasts","volume":"10","author":"Matijasevic","year":"1998","journal-title":"Oncol. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/5992\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:19:15Z","timestamp":1760138355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/5992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":80,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ijms23115992"],"URL":"https:\/\/doi.org\/10.3390\/ijms23115992","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]}}}